Aarti Drugs Ltd Share Price (AARTIDRUGS)
as on
| Source : NSE
Aarti Drugs Ltd Stock Performance
as on August 19, 2025 at 4:01 PM IST
Day's Low
Day's High
₹487.1₹506.95
0.74%
Downside
3.30%
Upside
52 Week's Low
52 Week's High
₹312₹63536.42%
Downside
29.39%
Upside
| Market Stats | |
| Previous Close | ₹503.85 |
| Open | ₹506.90 |
| Volume | 1.35L |
| Upper Circuit | ₹604.60 |
| Lower Circuit | ₹403.10 |
| Day's Low | ₹487.1 |
| Day's High | ₹506.95 |
| 52 Week Low | ₹312 |
| 52 Week High | ₹635 |
| Returns % | |
| 1 Month Return | -7.56 % |
| 3 Month Return | + 4.84 % |
| 1 Year Return | -4.33 % |
| 3 Year Return | + 12.82 % |
| 5 Year Return | -16.39 % |
Aarti Drugs Ltd Stock Fundamentals & Key Indicators
Check Aarti Drugs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹4,632.14 Cr
Return on Equity (ROE)
12.39
PE Ratio (TTM)
24.36
Return on capital employed (ROCE)
13.65
Industry PE ratio
43.29
Beta (LTM)
0.83
P/B Ratio
3.39
Dividend Yield
0.23
PEG Ratio
6.71
Quarterly Earnings Growth YOY
62.22
EPS (TTM)
18.66
Sector
Pharmaceuticals
Book Value
139.4
Technical Analysis
Bullish
View Technical Analysis
Aarti Drugs Ltd Stock's Interest Amongst Investors
Aarti Drugs Ltd Stock Valuation
Track how Aarti Drugs Ltd P/E has moved over time to understand its valuation trends.
Aarti Drugs Ltd in the last 5 years
Lowest (8.29x)
March 31, 2020
Today (24.36x)
August 18, 2025
Industry (43.29x)
August 18, 2025
Highest (57.24x)
August 24, 2020
Today’s Price to Earnings Ratio: 24.36x
Aarti Drugs Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Aarti Drugs Ltd.
based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Aarti Drugs Ltd. Average target price of ₹628
Source: S&P Global Market Intelligence
Aarti Drugs Ltd Share Price Target
Get share price movements and forecasts by analysts on Aarti Drugs Ltd.
Aarti Drugs Ltd price forecast by 1 analysts
Upside of24.64%
High
₹628
Target
₹628.00
Low
₹628
Aarti Drugs Ltd target price ₹628, a slight upside of 24.64% compared to current price of ₹490.75. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Aarti Drugs Ltd revenue growth forecast
Expected growth rate Q1, FY2027:22.29%
Forecast
Actual
Including amortisation and stock based compensations
Aarti Drugs Ltd EPS growth forecast
EPS estimate Q1, FY2027:74.26%
Forecast
Actual
Source: S&P Global Market Intelligence
Aarti Drugs Ltd Financial Results
Get the annual and quarterly financial summary of Aarti Drugs Ltd, including revenue, profit, loss and more.
Aarti Drugs Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Aarti Drugs Ltd.
Aarti Drugs Ltd Earnings Results
Aarti Drugs Ltd’s net profit jumped 62.18% since last year same period to ₹53.91Cr in the Q1 2025-2026. On a quarterly growth basis, Aarti Drugs Ltd has generated -14.24% fall in its net profits since last 3-months.
Read More about Earnings ResultsAarti Drugs Ltd Dividends January,2025
In the quarter ending December 2024, Aarti Drugs Ltd has declared dividend of ₹1.00 per share on 29 Jan 2025 - translating a dividend yield of 0.20%.
Read More about Dividends
Indices Featuring Aarti Drugs Ltd Stock
Check stock indices that include Aarti Drugs Ltd.
Aarti Drugs Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Aarti Drugs Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 55.22% | ||
| Foreign Institutions | 2.26% | 0.54 | |
| Mutual Funds | 9.85% | 12.46 | |
| Retail Investors | 32.58% | 0.03 | |
| Others | 0.09% |
Aarti Drugs Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Aarti Drugs Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 4,632.14 | -3.28% | 0.65 | 171 | 2,528 | |
| BUY | 34,329.66 | 33.03% | 0.52 | 300 | 1,051 | |
| BUY | 16,785.44 | 10.26% | 0.71 | 836 | 7,234 | |
| NA | 4,660.45 | -4.35% | 1.88 | -343 | 71 | |
| BUY | 15,826.83 | 49.24% | 0.67 | 244 | 1,515 |
Aarti Drugs Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Aarti Drugs Ltd.
Aarti Drugs Reports Strong Q1 Earnings Growth - 18 Jul, 2025
Aarti Drugs announced impressive Q1 results with a 62.7% increase in net profit and 6.3% revenue growth, driven by improved margins and operational efficiency.
Insights on Aarti Drugs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 32.57% to 32.58% in Jun 2025 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 2.25% to 2.26% in Jun 2025 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 8.75% to 9.85% in Jun 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, AARTIDRUGS stock has moved up by 31.5%
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 32.0% return, outperforming this stock by 36.3%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 136.7% return, outperforming this stock by 123.9%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 678.63 Cr → 590.82 Cr (in ₹), with an average decrease of 12.9% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 55.48% to 55.22% in Jun 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 62.86 Cr → 53.91 Cr (in ₹), with an average decrease of 14.2% per quarter
About Aarti Drugs Ltd
Revenue: ₹590.51Cr as on June 2025 (Q1 FY26)
Net Profit: ₹53.97Cr as on June 2025 (Q1 FY26)
Listing date: 03 Oct, 1996
Chairperson Name: Prakash M Patil
| Organisation | Aarti Drugs Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Prakash M Patil |
| E-voting on shares | Click here to vote |
Mutual Funds that own Aarti Drugs Ltd Stock
Check out the Mutual Funds with significant holdings in Aarti Drugs Ltd.
FAQs
What is Aarti Drugs Ltd share price today?
Aarti Drugs Ltd share price today stands at ₹490.75, Open: ₹506.9, Previous Close: ₹503.85, High: ₹506.95, Low: ₹487.1, 52 Week High: ₹635, 52 Week Low: ₹312 as on .
How to buy Aarti Drugs Ltd shares ?
To buy Aarti Drugs Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for AARTIDRUGS or Aarti Drugs Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Aarti Drugs Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Aarti Drugs Ltd?
Today's traded volume of Aarti Drugs Ltd is 1.35L. Which means that 1.35L shares of Aarti Drugs Ltd were bought and sold on the stock market during today's trading session.
What is Aarti Drugs Ltd's market cap today?
Today's market capitalisation of Aarti Drugs Ltd is ₹4,632.14 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Aarti Drugs Ltd?
Aarti Drugs Ltd’s 52 week high is ₹635 and 52 week low is ₹312. The current share price of Aarti Drugs Ltd is ₹490.75, which is -22.72% down from its 52 week high and 57.29% up from its 52 week low.